Solid-state nuclear magnetic resonance spectroscopy--pharmaceutical applications.
about
Acemetacin cocrystals and salts: structure solution from powder X-ray data and form selection of the piperazine saltCharacterization of the bulk properties of pharmaceutical solids using nonlinear optics--a review.Proton-detected solid-state NMR spectroscopy of natural-abundance peptide and protein pharmaceuticals.Acemetacin cocrystal structures by powder X-ray diffraction.Nonlinear optical imaging for sensitive detection of crystals in bulk amorphous powders.Rapid analysis of organic compounds by proton-detected heteronuclear correlation NMR spectroscopy with 40 kHz magic-angle spinning.Methods of amorphization and investigation of the amorphous state.Interactions between drugs and polymers influencing hot melt extrusion.Methods to characterize the structure of food powders - a review.Understanding Surface and Interfacial Chemistry in Functional Nanomaterials via Solid-State NMR.Detailed characterization of the dynamics of ibuprofen in the solid state by a multi-technique NMR approach.Testing the limits of sensitivity in a solid-state structural investigation by combined X-ray powder diffraction, solid-state NMR, and molecular modelling.DNP-enhanced solid-state NMR spectroscopy of active pharmaceutical ingredients.Assigning powders to crystal structures by high-resolution (1)H-(1)H double quantum and (1)H-(13)C J-INEPT solid-state NMR spectroscopy and first principles computation. A case study of penicillin G.Exploring conformational energy landscape of glassy disaccharides by cross polarization magic angle spinning 13C NMR and numerical simulations. I. Methodological aspects.Solid-State NMR Spectroscopy in Drug Design and DiscoveryNMR characterisation of dynamics in solvates and desolvates of formoterol fumarateSolid‐State NMR Studies of Pharmaceutical SystemsSolid-State NMR Applications in the Structural Elucidation of Small Molecules
P2860
Q30839515-5FF31611-7F73-4A1B-9A8E-D1C7BA2BAB98Q33271480-F01995E0-7AF4-44B3-A378-BC977A1A4434Q33610400-235207B5-8565-4871-9CB8-22C4F71A89E4Q33630701-3A96E6E5-450D-4DC5-83D8-65AF13180857Q36662432-B6C354FC-7C67-43D1-92AE-A1F30FDBE091Q37362168-F788DB64-A8ED-4C74-B510-FAA005355722Q38155018-BA681CC3-6D31-49F6-8367-702AB73C3EADQ38170190-74A616B5-EE7D-4F9B-9FAF-47563436353DQ39080112-5BF20359-BBCE-4A9B-8FB8-7C7230CE4C19Q39155973-DE5A2F85-5338-4579-A827-E6BEC29020B6Q43918246-CDA96351-26BA-4FEB-AEA3-81DFBFE142EEQ45376567-386DADD2-0B30-4141-84DA-C7A783ADAE7EQ47807784-A841FA4C-1278-43D8-9929-DEB5E1A27B2CQ51629744-2F37631F-A227-47F2-A26B-EF78728A8D5AQ53886678-E213B24E-4892-415D-8799-236241008AB6Q56835843-DACB505F-9BF6-4174-80D9-CA827E0E7F9FQ57096249-E51DC4B2-EF65-4592-B391-D2D60F3EA1F6Q57348567-CDE8031F-BC25-43AD-A3B9-F60B10227856Q57651136-1CAE2B49-3464-48DC-9AD5-34D6C4252262
P2860
Solid-state nuclear magnetic resonance spectroscopy--pharmaceutical applications.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Solid-state nuclear magnetic resonance spectroscopy--pharmaceutical applications.
@ast
Solid-state nuclear magnetic resonance spectroscopy--pharmaceutical applications.
@en
type
label
Solid-state nuclear magnetic resonance spectroscopy--pharmaceutical applications.
@ast
Solid-state nuclear magnetic resonance spectroscopy--pharmaceutical applications.
@en
prefLabel
Solid-state nuclear magnetic resonance spectroscopy--pharmaceutical applications.
@ast
Solid-state nuclear magnetic resonance spectroscopy--pharmaceutical applications.
@en
P2093
P356
P1476
Solid-state nuclear magnetic resonance spectroscopy--pharmaceutical applications.
@en
P2093
David E Bugay
Patrick A Tishmack
Stephen R Byrn
P304
P356
10.1002/JPS.10307
P407
P577
2003-03-01T00:00:00Z